Profile: Bioscan, Inc. develops instrumentation for the synthesis & detection of radiolabeled compounds used in life science research, pharmaceutical development and nuclear medicine. Our AR-2000 imaging scanner uses a gas-filled proportional counter, which detects all beta & gamma emitting isotopes. Our bioquest & genequest spectrophotometers are specifically designed for bioanalysis and molecular biology applications, such as DNA/RNA ratios, protein analysis, nucleic acids assays, reaction kinetics, bacterial growth & cell culture measurements. Our Chameleon V multilabel detection plate reader provides powerful & flexible platform for the broadest spectrum of measurement assays.

The company was founded in 1980, has revenues of USD 1-5 Million, has ~20 employees and is CE certified.